2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride

C185H195BBrCl4N25O9P4PdSi4 — CID 159834372

IUPAC2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride
SMILESC1COCCN1.C[Si](C)(C)CCOCn1cc2cc(-c3cccnc3)ccc2n1.C[Si](C)(C)CCOCn1cc2cc(Br)ccc2n1.C[Si](C)(C)CCOCn1nc2ccc(-c3cccnc3)cc2c1-c1cc(Cl)ncn1.C[Si](C)(C)CCOCn1nc2ccc(-c3cccnc3)cc2c1-c1cc(N2CCOCC2)ncn1.Cl.Clc1cc(Cl)ncn1.OB(O)c1cccnc1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1cncc(-c2ccc3c(c2)C(c2cc(N4CCOCC4)ncn2)=NC3)c1
InChIInChI=1S/C26H32N6O2Si.C22H24ClN5OSi.C21H19N5O.C18H23N3OSi.4C18H15P.C13H19BrN2OSi.C5H6BNO2.C4H2Cl2N2.C4H9NO.ClH.Pd/c1-35(2,3)14-13-34-19-32-26(24-16-25(29-18-28-24)31-9-11-33-12-10-31)22-15-20(6-7-23(22)30-32)21-5-4-8-27-17-21;1-30(2,3)10-9-29-15-28-22(20-12-21(23)26-14-25-20)18-11-16(6-7-19(18)27-28)17-5-4-8-24-13-17;1-2-16(12-22-5-1)15-3-4-17-13-23-21(18(17)10-15)19-11-20(25-14-24-19)26-6-8-27-9-7-26;1-23(2,3)10-9-22-14-21-13-17-11-15(6-7-18(17)20-21)16-5-4-8-19-12-16;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-18(2,3)7-6-17-10-16-9-11-8-12(14)4-5-13(11)15-16;8-6(9)5-2-1-3-7-4-5;5-3-1-4(6)8-2-7-3;1-3-6-4-2-5-1;;/h4-8,15-18H,9-14,19H2,1-3H3;4-8,11-14H,9-10,15H2,1-3H3;1-5,10-12,14H,6-9,13H2;4-8,11-13H,9-10,14H2,1-3H3;4*1-15H;4-5,8-9H,6-7,10H2,1-3H3;1-4,8-9H;1-2H;5H,1-4H2;1H;
InChIKeyZYUJHHXYAXNJPB-UHFFFAOYSA-N
MW3487.95 g/mol
LogP35.82
Rot. Bonds42

About 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride

2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride (PubChem CID 159834372) has the molecular formula C185H195BBrCl4N25O9P4PdSi4 and a molecular weight of 3487.95 g/mol. Its IUPAC name is 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride.

Molecular Properties

Compound Name2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride
PubChem CID159834372
Molecular FormulaC185H195BBrCl4N25O9P4PdSi4
Molecular Weight3487.95 g/mol
Exact Mass3482.07
IUPAC Name2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride
SMILESC1COCCN1.C[Si](C)(C)CCOCn1cc2cc(-c3cccnc3)ccc2n1.C[Si](C)(C)CCOCn1cc2cc(Br)ccc2n1.C[Si](C)(C)CCOCn1nc2ccc(-c3cccnc3)cc2c1-c1cc(Cl)ncn1.C[Si](C)(C)CCOCn1nc2ccc(-c3cccnc3)cc2c1-c1cc(N2CCOCC2)ncn1.Cl.Clc1cc(Cl)ncn1.OB(O)c1cccnc1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1cncc(-c2ccc3c(c2)C(c2cc(N4CCOCC4)ncn2)=NC3)c1
InChIInChI=1S/C26H32N6O2Si.C22H24ClN5OSi.C21H19N5O.C18H23N3OSi.4C18H15P.C13H19BrN2OSi.C5H6BNO2.C4H2Cl2N2.C4H9NO.ClH.Pd/c1-35(2,3)14-13-34-19-32-26(24-16-25(29-18-28-24)31-9-11-33-12-10-31)22-15-20(6-7-23(22)30-32)21-5-4-8-27-17-21;1-30(2,3)10-9-29-15-28-22(20-12-21(23)26-14-25-20)18-11-16(6-7-19(18)27-28)17-5-4-8-24-13-17;1-2-16(12-22-5-1)15-3-4-17-13-23-21(18(17)10-15)19-11-20(25-14-24-19)26-6-8-27-9-7-26;1-23(2,3)10-9-22-14-21-13-17-11-15(6-7-18(17)20-21)16-5-4-8-19-12-16;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-18(2,3)7-6-17-10-16-9-11-8-12(14)4-5-13(11)15-16;8-6(9)5-2-1-3-7-4-5;5-3-1-4(6)8-2-7-3;1-3-6-4-2-5-1;;/h4-8,15-18H,9-14,19H2,1-3H3;4-8,11-14H,9-10,15H2,1-3H3;1-5,10-12,14H,6-9,13H2;4-8,11-13H,9-10,14H2,1-3H3;4*1-15H;4-5,8-9H,6-7,10H2,1-3H3;1-4,8-9H;1-2H;5H,1-4H2;1H;
InChIKeyZYUJHHXYAXNJPB-UHFFFAOYSA-N
XLogP35.82
TPSA374.79 Ų
H-Bond Donors3
H-Bond Acceptors34
Rotatable Bonds42
Heavy Atoms234
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003487.95
LogP ≤ 535.82
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1034

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[[3-(6-chloropyrimidin-4-yl)-5-methylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,4-difluoropiperidine;2-[[3-[6-(4,4-difluoropiperidin-1-yl)pyrimidin-4-yl]-5-methylindazol-2-yl]methoxy]ethyl-trimethylsilane;2-[[3-[6-(4,4-difluoropiperidin-1-yl)pyrimidin-4-yl]-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;3-[6-(4,4-difluoropiperidin-1-yl)pyrimidin-4-yl]-5-pyridin-3-yl-1H-isoindole;pyridin-3-ylboronic acid;hydrochloride
CID 158089964
2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-chloropyrazine;2-[[3-(6-chloropyrimidin-4-yl)-5-pyrazin-2-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;4-[6-(6-pyrazin-2-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyrazin-2-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyrazin-2-ylindazol-2-yl)methoxy]ethyl]silane;trimethyl-[2-[[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-2-yl]methoxy]ethyl]silane;hydrochloride
CID 157761098
5-bromo-2-(cyclopropylmethyl)indazole;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[2-(cyclopropylmethyl)indazol-5-yl]-2-morpholin-4-ylpyrimidin-4-amine;2-(cyclopropylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole
CID 158045068
5-bromo-1H-isoindole;3-(6-chloropyrimidin-4-yl)-5-(1-methylpyrazol-4-yl)-1-tritylindazole;4,6-dichloropyrimidine;3-iodo-5-(1-methylpyrazol-4-yl)-1H-isoindole;3-iodo-5-(1-methylpyrazol-4-yl)-1-tritylindazole;methane;5-(1-methylpyrazol-4-yl)-1H-isoindole;4-[6-[5-(1-methylpyrazol-4-yl)-1-tritylindazol-3-yl]pyrimidin-4-yl]morpholine;1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole;morpholine;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
CID 159224027
6-bromo-1-methylpyrazolo[4,5-b]pyridine;bis(4-[4-chloro-6-(1-methylpyrazolo[4,5-b]pyridin-6-yl)pyrimidin-2-yl]morpholine);4-(4,6-dichloropyrimidin-2-yl)morpholine;methane;6-(1-methylpyrazolo[4,5-b]pyridin-6-yl)-N-[4-(5-methyl-4H-pyrazol-3-yl)phenyl]-2-morpholin-4-ylpyrimidin-4-amine;6-(1-methylpyrazolo[4,5-b]pyridin-6-yl)-2-morpholin-4-yl-N-[4-(4H-pyrazol-3-yl)phenyl]pyrimidin-4-amine;4-(5-methyl-4H-pyrazol-3-yl)aniline;1-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[4,5-b]pyridine;4-(4H-pyrazol-3-yl)aniline
CID 159235729
2-[(3-bromoindazol-1-yl)methoxy]ethyl-trimethylsilane;3-bromo-1H-isoindole;4-(6-chloropyrimidin-4-yl)morpholine;4-[6-(3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;methane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)indazol-1-yl]methoxy]ethyl]silane;trimethyl-[2-[[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyl]silane;hydrochloride
CID 159291644
2-[[5-bromo-3-(2-morpholin-4-yl-4-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;4-[4-[6-(1-methylimidazol-4-yl)-3H-isoindol-1-yl]-2-pyridinyl]morpholine;tributyl-(1-methylimidazol-4-yl)stannane;trimethyl-[2-[[5-(1-methylimidazol-4-yl)-3-(2-morpholin-4-yl-4-pyridinyl)indazol-1-yl]methoxy]ethyl]silane
CID 159483964
5-bromo-1-(cyclopropylmethyl)indazole;5-bromo-1H-isoindole;bromomethylcyclopropane;6-chloro-N-(4-chlorophenyl)-2-morpholin-4-ylpyrimidin-4-amine;N-(4-chlorophenyl)-6-[1-(cyclopropylmethyl)indazol-5-yl]-2-morpholin-4-ylpyrimidin-4-amine;1-(cyclopropylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole
CID 159814413
CID 160126037
CID 160126037
bis(2-[[3,5-bis(2-morpholin-4-yl-4-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane);2-[(5-bromo-3-iodoindazol-1-yl)methoxy]ethyl-trimethylsilane;2-[[5-bromo-3-(2-morpholin-4-yl-4-pyridinyl)indazol-1-yl]methoxy]ethyl-trimethylsilane;(2-morpholin-4-yl-4-pyridinyl)boronic acid;4-[4-[3-(2-morpholin-4-yl-4-pyridinyl)-1H-isoindol-5-yl]-2-pyridinyl]morpholine
CID 160544703

Frequently Asked Questions

What is the IUPAC name of 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride?
The IUPAC name of 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride (CID 159834372) is 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride.
What is the SMILES notation for 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride?
The canonical SMILES for 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride is C1COCCN1.C[Si](C)(C)CCOCn1cc2cc(-c3cccnc3)ccc2n1.C[Si](C)(C)CCOCn1cc2cc(Br)ccc2n1.C[Si](C)(C)CCOCn1nc2ccc(-c3cccnc3)cc2c1-c1cc(Cl)ncn1.C[Si](C)(C)CCOCn1nc2ccc(-c3cccnc3)cc2c1-c1cc(N2CCOCC2)ncn1.Cl.Clc1cc(Cl)ncn1.OB(O)c1cccnc1.[Pd].c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1ccc(P(c2ccccc2)c2ccccc2)cc1.c1cncc(-c2ccc3c(c2)C(c2cc(N4CCOCC4)ncn2)=NC3)c1.
What is the InChIKey of 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride?
The InChIKey is ZYUJHHXYAXNJPB-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H32N6O2Si.C22H24ClN5OSi.C21H19N5O.C18H23N3OSi.4C18H15P.C13H19BrN2OSi.C5H6BNO2.C4H2Cl2N2.C4H9NO.ClH.Pd/c1-35(2,3)14-13-34-19-32-26(24-16-25(29-18-28-24)31-9-11-33-12-10-31)22-15-20(6-7-23(22)30-32)21-5-4-8-27-17-21;1-30(2,3)10-9-29-15-28-22(20-12-21(23)26-14-25-20)18-11-16(6-7-19(18)27-28)17-5-4-8-24-13-17;1-2-16(12-22-5-1)15-3-4-17-13-23-21(18(17)10-15)19-11-20(25-14-24-19)26-6-8-27-9-7-26;1-23(2,3)10-9-22-14-21-13-17-11-15(6-7-18(17)20-21)16-5-4-8-19-12-16;4*1-4-10-16(11-5-1)19(17-12-6-2-7-13-17)18-14-8-3-9-15-18;1-18(2,3)7-6-17-10-16-9-11-8-12(14)4-5-13(11)15-16;8-6(9)5-2-1-3-7-4-5;5-3-1-4(6)8-2-7-3;1-3-6-4-2-5-1;;/h4-8,15-18H,9-14,19H2,1-3H3;4-8,11-14H,9-10,15H2,1-3H3;1-5,10-12,14H,6-9,13H2;4-8,11-13H,9-10,14H2,1-3H3;4*1-15H;4-5,8-9H,6-7,10H2,1-3H3;1-4,8-9H;1-2H;5H,1-4H2;1H;.
What are the key properties of 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride?
2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride has a molecular weight of 3487.95 g/mol, XLogP of 35.82, 42 rotatable bonds, 3 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(5-bromoindazol-2-yl)methoxy]ethyl-trimethylsilane;2-[[3-(6-chloropyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl-trimethylsilane;4,6-dichloropyrimidine;morpholine;palladium;pyridin-3-ylboronic acid;4-[6-(6-pyridin-3-yl-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;trimethyl-[2-[[3-(6-morpholin-4-ylpyrimidin-4-yl)-5-pyridin-3-ylindazol-2-yl]methoxy]ethyl]silane;trimethyl-[2-[(5-pyridin-3-ylindazol-2-yl)methoxy]ethyl]silane;tetrakis(triphenylphosphane);hydrochloride is sourced from PubChem (CID 159834372), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).